Nakamura Y - Search Results

1

Cardiohemodynamic and electrophysiological effects of a selective EP4 receptor agonist ONO--AE1--329 in the halothane-anesthetized dogs.

Nomura H, Nakamura Y, Cao X, Honda A, Katagi J, Ohara H, Izumi-Nakaseko H, Satoh Y, Ando K, Sugiyama A. Nomura H, et al. Among authors: nakamura y. Eur J Pharmacol. 2015 Aug 15;761:217-25. doi: 10.1016/j.ejphar.2015.06.012. Epub 2015 Jun 11. Eur J Pharmacol. 2015. PMID: 26073024

2

Analysis of proarrhythmic potential of antipsychotics risperidone and olanzapine in anesthetized dogs.

Ando K, Sugiyama A, Takahara A, Satoh Y, Ishizaka T, Nakamura Y, Hashimoto K. Ando K, et al. Among authors: nakamura y. Eur J Pharmacol. 2007 Mar 8;558(1-3):151-8. doi: 10.1016/j.ejphar.2006.11.078. Epub 2006 Dec 12. Eur J Pharmacol. 2007. PMID: 17239365

3

Cardiac effects of L/N-type Ca2+ channel blocker cilnidipine in anesthetized dogs.

Takahara A, Iwasaki H, Nakamura Y, Sugiyama A. Takahara A, et al. Among authors: nakamura y. Eur J Pharmacol. 2007 Jun 22;565(1-3):166-70. doi: 10.1016/j.ejphar.2007.03.025. Epub 2007 Mar 24. Eur J Pharmacol. 2007. PMID: 17445796

4

Cardiovascular profile of the canine torsades de pointes arrhythmia model assessed by echocardiographic and haemodynamic methods.

Takahara A, Sugiyama A, Satoh Y, Iwasaki H, Nakamura Y, Hashimoto K. Takahara A, et al. Among authors: nakamura y. Basic Clin Pharmacol Toxicol. 2007 Jul;101(1):35-40. doi: 10.1111/j.1742-7843.2007.00071.x. Basic Clin Pharmacol Toxicol. 2007. PMID: 17577314 Free article.

5

Beat-to-beat variability of repolarization differentiates the extent of torsadogenic potential of multi ion channel-blockers bepridil and amiodarone.

Takahara A, Nakamura Y, Sugiyama A. Takahara A, et al. Among authors: nakamura y. Eur J Pharmacol. 2008 Oct 31;596(1-3):127-31. doi: 10.1016/j.ejphar.2008.08.018. Epub 2008 Aug 30. Eur J Pharmacol. 2008. PMID: 18786527

6

Effects of selective IKr channel blockade by E-4031 on ventricular electro-mechanical relationship in the halothane-anesthetized dogs.

Izumi-Nakaseko H, Nakamura Y, Cao X, Ohara H, Yamazaki Y, Ueda N, Ando K, Sugiyama A. Izumi-Nakaseko H, et al. Among authors: nakamura y. Eur J Pharmacol. 2014 Oct 5;740:263-70. doi: 10.1016/j.ejphar.2014.06.064. Epub 2014 Jul 17. Eur J Pharmacol. 2014. PMID: 25038475

7

Analysis of Onset Mechanisms of a Sphingosine 1-Phosphate Receptor Modulator Fingolimod-Induced Atrioventricular Conduction Block and QT-Interval Prolongation.

Yagi Y, Nakamura Y, Kitahara K, Harada T, Kato K, Ninomiya T, Cao X, Ohara H, Izumi-Nakaseko H, Suzuki K, Ando K, Sugiyama A. Yagi Y, et al. Among authors: nakamura y. Toxicol Appl Pharmacol. 2014 Nov 15;281(1):39-47. doi: 10.1016/j.taap.2014.09.006. Epub 2014 Sep 16. Toxicol Appl Pharmacol. 2014. PMID: 25223691

8

Intravenous Administration of Apomorphine Does NOT Induce Long QT Syndrome: Experimental Evidence from In Vivo Canine Models.

Watanabe Y, Nakamura Y, Cao X, Ohara H, Yamazaki Y, Murayama N, Sugiyama Y, Izumi-Nakaseko H, Ando K, Yamazaki H, Sugiyama A. Watanabe Y, et al. Among authors: nakamura y. Basic Clin Pharmacol Toxicol. 2015 Jun;116(6):468-75. doi: 10.1111/bcpt.12343. Epub 2014 Nov 22. Basic Clin Pharmacol Toxicol. 2015. PMID: 25370785 Free article.

9

Fluvoxamine by itself has potential to directly induce long QT syndrome at supra-therapeutic concentrations.

Yamazaki-Hashimoto Y, Nakamura Y, Ohara H, Cao X, Kitahara K, Izumi-Nakaseko H, Ando K, Yamazaki H, Ikeda T, Yamazaki J, Sugiyama A. Yamazaki-Hashimoto Y, et al. Among authors: nakamura y. J Toxicol Sci. 2015 Feb;40(1):33-42. doi: 10.2131/jts.40.33. J Toxicol Sci. 2015. PMID: 25560394 Free article.

10

Why Can dl-Sotalol Prolong the QT Interval In Vivo Despite Its Weak Inhibitory Effect on hERG K(+) Channels In Vitro? Electrophysiological and Pharmacokinetic Analysis with the Halothane-Anesthetized Guinea Pig Model.

Katagi J, Nakamura Y, Cao X, Ohara H, Honda A, Izumi-Nakaseko H, Ando K, Sugiyama A. Katagi J, et al. Among authors: nakamura y. Cardiovasc Toxicol. 2016 Apr;16(2):138-46. doi: 10.1007/s12012-015-9322-2. Cardiovasc Toxicol. 2016. PMID: 25822712

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

14,628 results

Search Page

Filters